HDLG:LSE:LSE-Invesco S&P 500 High Dividend Low Volatility UCITS ETF (GBX)

ETF | Others |

Last Closing

USD 3004

Change

0.00 (0.00)%

Market Cap

N/A

Volume

9.65K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNIF:LSE Xtrackers Nifty 50 Swap UCITS ..

N/A

USD 292,109.69B
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

N/A

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

N/A

USD 701.81B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 636.56B
0R1I:LSE NVIDIA Corp.

N/A

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

N/A

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

N/A

USD 260.39B
0QZO:LSE 0QZO

N/A

USD 258.54B

ETFs Containing HDLG:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.23% 73% C 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.23% 73% C 66% D+
Trailing 12 Months  
Capital Gain 18.59% 87% B+ 79% B-
Dividend Return 0.04% 27% F 24% F
Total Return 18.63% 86% B+ 78% C+
Trailing 5 Years  
Capital Gain 28.95% 47% F 59% D-
Dividend Return 0.21% 34% F 46% F
Total Return 29.16% 45% F 58% F
Average Annual (5 Year Horizon)  
Capital Gain 8.99% 58% F 63% D
Dividend Return 9.01% 57% F 62% D
Total Return 0.01% 26% F 18% F
Risk Return Profile  
Volatility (Standard Deviation) 13.13% 55% F 72% C
Risk Adjusted Return 68.60% 67% D+ 79% B-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.